We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Transforms Colonoscopy by Improving Detection and Reducing Missed Rates

By HospiMedica International staff writers
Posted on 06 Dec 2023

Colorectal cancer ranks among the top three most common types of cancer globally and is a significant factor in cancer-related deaths. More...

A primary strategy to reduce colorectal cancer incidence involves early detection and removal of adenomatous polyps via colonoscopy. It's noted that a 1% increase in the adenoma detection rate typically corresponds to a 3% decrease in colorectal cancer risk. However, there's an estimated 27% rate of missed adenomas during endoscopy that can be attributed to cognitive or technical errors. Recently, the use of artificial intelligence (AI) has been explored to enhance polyp detection during colonoscopies, aiming to minimize human error. Despite this, inconsistencies in research outcomes concerning AI-based adenoma detection tools and concerns regarding overdiagnosis, which could lead to unnecessary patient stress and costs, persist.

In a new study, researchers at Harbin Medical University (Harbin, China) undertook an extensive review of randomized controlled trials to assess the pros and cons of AI-based systems in adenoma detection, comparing them with traditional colonoscopy methods. This thorough meta-analysis intended to deepen the understanding of AI-assisted detection of colorectal neoplasia. The findings revealed that AI-enhanced colonoscopy methods significantly improved the detection of colorectal neoplasia and markedly reduced the rates of missed adenomas and polyps. These AI-assisted studies also reported notable increases in both polyp and adenoma detection rates, including the average number of adenomas and polyps identified per colonoscopy procedure.

Specifically, the miss rate for polyps using AI-based colonoscopy methods was reduced by 52.5%, and the polyp detection rate was 23.8% higher compared to standard procedures. Additionally, the number of polyps discovered per colonoscopy was higher by 0.271 when utilizing AI-based methods. However, there was considerable variability in outcomes related to polyp detection across these studies. Likewise, the adenoma detection rate improved by 24.2%, and the adenoma miss rate decreased by 50.5% with AI methods. On average, 0.202 more adenomas were detected per colonoscopy using AI-enhanced detection techniques. Yet, these trials also displayed significant heterogeneity in their adenoma detection results.

The study findings indicate that AI-integrated colonoscopy could substantially improve adenoma and colorectal neoplasia detection rates. Minor enhancements in colonoscopy quality could lead to significant benefits in large-scale colorectal cancer screening programs, contributing to uniformity and improved quality in colonoscopy procedures. The research team believes there is a need for further long-term studies to validate the long-term effectiveness of AI-based colonoscopy methods in reducing the rates of morbidity and mortality associated with colorectal cancer.

Related Links:
Harbin Medical University


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.